Needham reaffirmed its Buy rating on Rocket Lab USA, Inc. (NASDAQ:RKLB) and increased its price target from $28 to $32 on May 28. The adjustment was announced following the news that Rocket Lab will ...

Rocket Lab’s strategy has centered on acquiring key technologies and bringing them in-house to control cost, reduce schedule ...

Rocket Lab is entering the payload market and deepening its involvement in national security space by acquiring ...

Severe floods in Romania are threatening to destroy the Praid salt mine, one of Europe's largest salt reserves which attracts ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the ...

Intellia Therapeutics shares fell 25% amid safety concerns in Phase 3 trials. Check out if today's selloff in NTLA stock is a ...

The EU's gross available energy fell by 4.1% in 2023, but Europe is now doing more with less. Renewables now supply 19.5% of ...